ABBV - Revance Therapeutics: The Real Threat To Abbvie's Dividend
Editor's note: Seeking Alpha is proud to welcome Robert Falcone as a new contributor. It's easy to become a Seeking Alpha contributor and earn money for your best investment ideas. Active contributors also get free access to SA PREMIUM. Click here to find out more »
Introduction
Let's face it, it has been a monster year for M&A throughout healthcare. It seems like companies are taking on astronomical amounts of debt (albeit at historically low rates) in an effort to grow revenue and earnings in this highly competitive environment. My level of bullishness in the